For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent ...

The European Medicines Agency (EMA) has warned that popular weight-loss and diabetes drugs containing semaglutide — including ...

Patients who remained on treatment, especially at higher doses or on tirzepatide, were more likely to achieve clinically ...

The following is a summary of “Oral semaglutide for the treatment of obesity: a retrospective real-world study,” published in ...

Diabetic weight loss medications are effective for people with schizophrenia without affecting psychotic symptoms, University ...

Pharmacovigilance Risk Assessment Committee (PRAC) has concluded its review of semaglutide-containing medicines, confirming a ...

Given the evidence, the committee has recommended that the labels for Novo Nordisk’s Wegovy and Ozempic be updated to include ...

The EMA’s drug safety committee launched a review of medicines containing semaglutide — the active ingredient in Ozempic, ...